Kuros Biosciences AG is a Swiss biotechnology company that develops products for bone regeneration and spinal fusion. Its portfolio centres on synthetic bone graft substitutes used by orthopaedic and spine surgeons, along with a biologic candidate intended to stimulate bone formation in spinal procedures. The company serves hospitals and surgical specialists, and it is based in Schlieren, Switzerland, where it carries out its research and development work.
On this site Kuros Biosciences AG appears as a stock on the SIX Swiss Exchange (Switzerland), code KURN, with prices in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #204 of 226 on the SIX Swiss Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Switzerland yet.
TrendWeak
13/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-9.1%
From 52-week high-37.8%
MomentumWeak
20/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-2.5%
6-month return-10.3%
12-month, skipping last month-39.7%
Stability (higher is calmer)Weak
12/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)51.9%
Worst drawdown, 1 year (smaller is calmer)-48.6%
LiquidityFair
68/100
Moderate trading activity.
See the numbers →
Avg daily value traded4.48M CHF
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Switzerland when fundamentals data for this market is added. All Switzerland stocks.
52-wk range 16.46 – 32.48Daily closes, split-adjusted
Signals
50-day average18.95
200-day average21.89
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.22
Technical summary
Daily
Bullish
9 bullish · 3 neutral · 4 bearish
Weekly
Neutral
5 bullish · 1 neutral · 6 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
19.19
Bullish
EMA 10
19.51
Bullish
SMA 20
18.82
Bullish
EMA 20
19.04
Bullish
SMA 50
18.95
Bullish
EMA 50
19.14
Bullish
SMA 100
19.81
Bullish
EMA 100
19.95
Bearish
SMA 200
21.89
Bearish
EMA 200
21.36
Bearish
Oscillators (daily)
RSI (14)
55.38
Neutral
MACD (12, 26)
0.41
Bullish
Momentum (12)
10.56
Bullish
Stochastic %K (14)
63.77
Neutral
Williams %R (14)
-36.23
Neutral
CCI (20)
136.8
Bearish
Pivot points (classic, last session)
S3
18.00
S2
18.90
S1
19.40
Pivot
20.30
R1
20.80
R2
21.70
R3
22.20
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CHF. Educational only, not financial advice.
